Schizophrenia, Catatonic: Clinical Trials

2 trials for Schizophrenia, Catatonic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 21Completed 1

Follow Schizophrenia, Catatonic: new trials by email Literature Review of Schizophrenia, Catatonic trials Research Report on Schizophrenia, Catatonic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia
t-VNS verum, t-VNS placebo - Schizophrenia
Phase 2Completedcerbomed GmbH202010-03-012012-09-12
Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
Long-acting Risperidone microspheres injection - Schizophrenia, Catatonic, Schizophrenia, Disorganized
Not applicableUnknownHospital Authority, Hong Kong302004-10-012010-07-07

Narrower conditions

Psychotic Disorders (2)  ·  Schizophrenia (2)  ·  Schizophrenia, Disorganized (2)  ·  Schizophrenia, Paranoid (2)  ·  Delusions (1)  ·  Dementia (1)  ·  Hallucinations (1)  ·  Illusions (1)  ·  Mental Disorders (1)  ·  Neuroleptic Malignant Syndrome (1)  ·  Tardive Dyskinesia (1)

Broader conditions

Schizophrenia Spectrum and Other Psychotic Disorders (2)  ·  Basal Ganglia Diseases (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Dyskinesia, Drug-Induced (1)  ·  Dyskinesias (1)  ·  Mental Disorders (1)  ·  Movement Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurocognitive Disorders (1)  ·  Neurologic Manifestations (1)

Sponsors

Hospital Authority, Hong Kong (1)  ·  cerbomed GmbH (1)

Countries

China (1)  ·  Germany (1)

Top investigators

Wing King Lee, Dr (1)